Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Islet cell replacement therapy - Sernova

Next Previous
Search
Drug Profile

Islet cell replacement therapy - Sernova

Alternative Names: Cell Pouch™ - donor islet cells; Islands-of-Langerhans transplantation; Islet cell therapy; Islet transplantation; Islet-of-Langerhans cell replacement therapy; Islets-of-Langerhans transplantation; Pancreatic islets transplantation

Latest Information Update: 18 Sep 2024

Price :
$50 *
Note:
  • Adis is an information provider. We do not sell or distribute actual drugs.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase.
  • A link to download a PDF version of the drug profile will be included in your email receipt.

At a glance

  • Originator Sernova Corp
  • Developer Sernova Corp; University of Alberta; University of Chicago
  • Class Antihyperglycaemics; Cell therapies
  • Mechanism of Action Pancreatic beta cell replacements
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity No
  • Available For Licensing Yes - Haemophilia A; Type 1 diabetes mellitus

Highest Development Phases

  • Phase I/II Type 1 diabetes mellitus

Most Recent Events

  • 12 Sep 2024 Interim efficacy, adverse events and pharmacodynamics data from a phase I/II trial in Type 1 diabetes mellitus released by Sernova Corp
  • 02 Apr 2024 Updated efficacy data from a phase I/II trial in Type 1 diabetes mellitus were released by Sernova
  • 26 Mar 2024 AgeX Therapeutics has merged with Serina Therapeutics to form Serina Therapeutics

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:
  • Contacting your organization’s admin about adding this content to your AdisInsight subscription
  • Buying a PDF version of any individual profile
  • Request a free trial
If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top